Genetic Disturbance

I would like to take exception to the views presented by Garland E. Allen in the February 6, 1989, issue of The Scientist (page 9). Allen sees a resurgence in both the scientific and the popular presses, of reports of new evidence suggesting genetic contributions to the development and expression of complex social behaviors, such as alcoholism, shyness, and manic depressive illness. Allen finds the appearance of these reports threatening to the public, in that historically such ideas were used

Written byLinda Mealey
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I would like to take exception to the views presented by Garland E. Allen in the February 6, 1989, issue of The Scientist (page 9). Allen sees a resurgence in both the scientific and the popular presses, of reports of new evidence suggesting genetic contributions to the development and expression of complex social behaviors, such as alcoholism, shyness, and manic depressive illness. Allen finds the appearance of these reports threatening to the public, in that historically such ideas were used for political purposes to “blame the victim” and turn attention away from the failure of government to moderate environmental contributions to social problems. Allen is, I believe, rightfully concerned about the potential misuses of science, but to lump together all research on the genetic bases of social behavior and reject it on the grounds of being both poor science and poor politics is absurd and inflammatory. I believe that attacks ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies